Cytrx Corp - Net Worth and Insider Trading

Cytrx Corp Net Worth

The estimated net worth of Cytrx Corp is at least $4 dollars as of 2024-05-06. Cytrx Corp is the 10% Owner of Phio Pharmaceuticals Corp and owns about 5 shares of Phio Pharmaceuticals Corp (PHIO) stock worth over $4. Cytrx Corp is also the 10% Owner of SELLAS Life Sciences Group Inc and owns about 0 shares of SELLAS Life Sciences Group Inc (SLS) stock worth over $0. Details can be seen in Cytrx Corp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cytrx Corp has not made any transactions after 2010-12-29 and currently still holds the listed stock(s).

Transaction Summary of Cytrx Corp

To

Cytrx Corp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cytrx Corp owns 1 companies in total, including SELLAS Life Sciences Group Inc (SLS) .

Click here to see the complete history of Cytrx Corp’s form 4 insider trades.

Insider Ownership Summary of Cytrx Corp

Ticker Comapny Transaction Date Type of Owner
SLS SELLAS Life Sciences Group Inc 2010-12-29 10 percent owner

Cytrx Corp Latest Holdings Summary

Cytrx Corp currently owns a total of 2 stocks. Among these stocks, Cytrx Corp owns 5 shares of Phio Pharmaceuticals Corp (PHIO) as of February 14, 2008, with a value of $4 and a weighting of 100%. Cytrx Corp also owns 0 shares of SELLAS Life Sciences Group Inc (SLS) as of December 29, 2010, with a value of $0 and a weighting of 0%.

Latest Holdings of Cytrx Corp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PHIO Phio Pharmaceuticals Corp 2008-02-14 5 0.82 4
SLS SELLAS Life Sciences Group Inc 2010-12-29 0 1.33 0

Holding Weightings of Cytrx Corp


Cytrx Corp Form 4 Trading Tracker

According to the SEC Form 4 filings, Cytrx Corp has made a total of 0 transactions in Phio Pharmaceuticals Corp (PHIO) over the past 5 years. The most-recent trade in Phio Pharmaceuticals Corp is the sale of 0 shares on February 14, 2008, which brought Cytrx Corp around $0.

According to the SEC Form 4 filings, Cytrx Corp has made a total of 0 transactions in SELLAS Life Sciences Group Inc (SLS) over the past 5 years. The most-recent trade in SELLAS Life Sciences Group Inc is the sale of 86 shares on December 29, 2010, which brought Cytrx Corp around $6 Million.

Insider Trading History of Cytrx Corp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cytrx Corp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cytrx Corp Ownership Network

Ownership Network List of Cytrx Corp

No Data

Ownership Network Relation of Cytrx Corp


Cytrx Corp Owned Company Details

What does SELLAS Life Sciences Group Inc do?

Who are the key executives at SELLAS Life Sciences Group Inc?

Cytrx Corp is the 10 percent owner of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .

SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary

Over the past 18 months, Cytrx Corp made no insider transaction in SELLAS Life Sciences Group Inc (SLS). Other recent insider transactions involving SELLAS Life Sciences Group Inc (SLS) include a net sale of 6,494 shares made by Angelos M. Stergiou , a net sale of 2,153 shares made by Barbara A Wood , and a net sale of 1,159 shares made by John Thomas Burns .

In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,806 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,806 shares.

SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

SELLAS Life Sciences Group Inc Insider Transactions

No Available Data

Cytrx Corp Mailing Address

Above is the net worth, insider trading, and ownership report for Cytrx Corp. You might contact Cytrx Corp via mailing address: 11726 San Vicente Boulevard, Suite 650, Los Angeles Ca 90049.

Discussions on Cytrx Corp

No discussions yet.